Impact of cilostazol on infrapopliteal angioplasty

Phase 2

• Conditions: Peripheral arterial disease.; Peripheral vascular disease, unspecified; I73.9

• Registration Number: IRCT20190418043306N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with Lower Limb Ischemia
age over 40 years

Exclusion Criteria

Patients with congestive heart failure
Patiets with previous lower exterimity endovascular therpy
Patients with previous lower exterimity bypass surgery

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relief of lower extremity ischemic symptoms based on Rutherford classification. Timepoint: Documentation of lower extremity ischemic symptoms based on Rutherford classification in the beginning of trial and after 3 months of medicine consumption. Method of measurement: Measurement of severity of symptoms based on Rutherford classification.